The most influential Megatrends set to shape the world through 2030, identified by Euromonitor International, help businesses better anticipate market developments and lead change for their industries.
Learn moreEuromonitor addresses your unique questions and challenges across all B2B and B2C industries and geographies through custom, tailor-made research projects, designed to your specific goals.
Learn moreNov 2020
US$990Added to Cart
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extract FREE!
Following the emergence of COVID-19 in the United Arab Emirates and the initial stages of the lockdown, only essential stores such as grocery retailers and chemists/pharmacies were allowed to remain open, resulting in consumers rushing to stock up on various cough and cold remedies in order to be better prepared to treat symptoms of a possible COVID-19 infection. The initial months of lockdown benefited more obscure and local players since stock of international brands were quickly diminished as customers began to panic, a trend which supported further growth through the smaller distribution of e-commerce, offering a viable alternative to major retailers in addition to convenience for those wishing to self-isolate.
Due to the fears associated with COVID-19 (with symptoms of the virus being similar to those of certain allergies) residents have become increasingly willing to find ways to alleviate this issue because they will be denied entry into their workplace if they show symptoms. Furthermore, as an increasing number of consumers are forced to stay indoors during lockdown, they will be exposed to house dust mites which is a dominant cause of allergy rhinitis in the country in addition to air conditioning.
GSK Consumer Healthcare is set to retain its notable lead of cough, cold and allergy (hay fever) remedies in 2020, as it benefits from a large product portfolio that includes trusted brands Panadol and Otrivin (decongestants) which treat the symptoms of coughs, colds, and flu, while its Zyrtec brand is ranked second in antihistamines/allergy remedies (systemic). Panadol’s presence in particular has expanded in modern grocery retailers, a distribution channel that is predicted to gain further value share in 2020 due to its convenience as a one-stop store for consumers during the pandemic.
Files are delivered directly into your account within a few minutes of purchase.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.
Delivery: Files are delivered directly into your account within a few minutes of purchase.
Overview
Discover the latest market trends and uncover sources of future market growth for the Cough, Cold and Allergy (Hay Fever) Remedies industry in United Arab Emirates with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Cough, Cold and Allergy (Hay Fever) Remedies industry in United Arab Emirates, our research will save you time and money while empowering you to make informed, profitable decisions.
The Cough, Cold and Allergy (Hay Fever) Remedies in United Arab Emirates market research report includes:
Our market research reports answer questions such as:
Why buy this report?
This industry report originates from Passport, our Consumer Health market research database.
Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.